Transforming IgA Nephropathy Care: The Promise of New and Emerging Targeting Therapies

Join leading experts for an engaging discussion exploring the evolving science behind IgAN pathogenesis and treatment. You'll gain a deeper understanding of the role of complement, endothelin, and APRIL/BAFF in IgAN progression-and how they are being harnessed as novel therapeutic targets. A dynamic 2D animation will bring the mechanisms of these targeted agents to life, while expert insights into the latest data and guidelines will support the evidence-based treatment of your patients with IgAN. The program will conclude with an interactive case discussion and a live "Ask the Expert" Q&A session, where you can engage directly with IgAN thought leaders and refine your approach to individualized care.